Colorado BioScience Association appoints new board leadership

Wednesday, May 24, 2017

Terumo BCT General Counsel Scott Larson named chairman of the board  

Nivalis Therapeutics acquired by Seattle-based Alpine Immune Systems

Tuesday, April 18, 2017

A Seattle biotech company is acquiring Boulder’s Nivalis Therapeutics, merging with it to become publicly traded and use Nivalis’ $44 million in cash to fund new immunotherapy cancer and inflammatory disease treatments. 

CU Boulder Study: Federally-Funded Laboratories and Institutions Have a $2.6 Billion Annual Impact in Colorado

Thursday, March 23, 2017

CU Boulder Study: Federally-Funded Laboratories and Institutions Have a $2.6 Billion Annual Impact in Colorado  

Health-Tech Innovators Advocate For Colorado’s Advanced Industries Grants

Tuesday, February 21, 2017

DENVER, Colo. – A culture of collaboration has made Colorado the #1 Health Innovation ecosystem in the United States today.

Organizations like Prime Health, the Colorado Bioscience Association (CBSA), Innosphere and the Office of Economic Development and International Trade (OEDIT), are working on behalf of the ecosystem to support programs and funding that drive innovation and acceleration commercialization.

One of the qualities that make Colorado unique for entrepreneurs is the publicly supported advanced industries grants and tax credits run by OEDIT. These programs encourage private investors to provide funding for local companies with high growth potential.

Full story at CyberMed News

Continue Reading

Boomtown Accelerator forges relationship with Colorado BioScience Association

Wednesday, January 11, 2017

BOULDER, Colo — Jan. 10, 2017 — Boomtown, a startup accelerator that nurtures selected startups through a 12-week mentoring program, is excited to announce that they have established a relationship with the Colorado BioScience Association (CBSA). 

Biodesix® and Bioyong Announce Agreement for Joint Development and Commercialization of VeriStrat® Test in Greater China

Monday, January 09, 2017

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. and Bioyong Technology Company Ltd. (Beijing, China) announced today that they have entered into an international collaboration agreement where Bioyong will develop and commercialize a version of Biodesix’s VeriStrat® proteomic blood test, a precision medicine diagnostic for patients with non-small cell lung cancer (NSCLC), for clinical use in Greater China, with potential expansion into other Asia-Pacific countries. 

Gov. Hickenlooper announces "Call for Innovation" to help underserved Colorado Youth

Monday, January 09, 2017

Gov. John Hickenlooper today announced the “Colorado Call for Innovation,” soliciting innovative approaches from nonprofits, local governments and service providers to improve outcomes for Colorado underserved youth and their families. 

Clovis raises $205M in bumped-up follow-on

Thursday, January 05, 2017

Clovis Oncology Inc. (NASDAQ:CLVS) raised $205 million through the sale of 5 million shares at $41 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, Stifel and SunTrust. The price is a 7.7% discount to Clovis' closing price of $44.42 on Friday, before the offering was proposed. 

SomaLogic announces that it has joined the iCarbonX Digital Life Alliance

Thursday, January 05, 2017

BOULDER, Colo. – January 5, 2017 – SomaLogic announced today that it has agreed to join the “Digital Life Alliance” established by iCarbonX, the China-based company founded in 2015 to build a “Global Digital Health Ecosystem that can define each person’s ‘digital life’ based on a combination of individual’s biological, behavioral and psychological data, the Internet and artificial intelligence.” Under the agreement between the companies, SomaLogic will provide proteomics data and applications expertise to the Alliance to accelerate the ecosystem’s development. Also under the agreement, iCarbonX and SomaLogic will establish a joint venture in China to provide the SOMAscan® proteomics assay for research and health applications in China. The iCarbonX ecosystem will also make an equity investment in SomaLogic to help accelerate these efforts. 

Flashback Technologies wins de novo FDA nod for blood loss algorithm

Wednesday, January 04, 2017

Predictive data analytics company Flashback Technologies said today it won FDA de novo clearance for devices using its Compensatory Reserve Index algorithm, now cleared as an adjunctive cardiovascular status indicator.